ELV — ELEVANCE HEALTH INC FORMERLY
Health Care · Healthcare Plans
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ELV?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their ELV position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.
- +5 tracked investors reported holding ELV at their latest filing
- −2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About ELEVANCE HEALTH INC FORMERLY (ELV)
ELEVANCE HEALTH INC FORMERLY (ELV) appears in the most recent 13F filings of 5 tracked institutional investors. ELEVANCE HEALTH INC FORMERLY is classified in the Health Care sector (Healthcare Plans industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $555M. Across recent filings, tracked investors recorded 4 new positions, 13 increased, 13 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ELV
How many top investors track ELV
A small number of top investors own this.
ELV Ownership Composition
How ELEVANCE HEALTH INC FORMERLY is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant62.9%
- Value & Distressed36.7%
- Macro0.4%
Tracked investors currently reporting ELV
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares1.3MValue$496.7M% Portfolio0.06%
- Seth KlarmanJun 30, 2026Baupost GroupShares1.3MValue$493.1M% Portfolio9.11%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares836.9KValue$323.6M% Portfolio0.12%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares67.3KValue$26M% Portfolio0.03%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares14.5KValue$5.6M% Portfolio0.01%
Previously held ELV
These investors reported ELV in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Ray Dalio | Bridgewater Associates | 58.8K | $22.9M | Jun 30, 2025 |
Recent activity
- New$107MMay 14, 2025
- Increased$239.6M(150.41%)Aug 13, 2025
- Increased$426.2M(114.12%)Nov 13, 2025
- Reduced$445M(-3.77%)Feb 13, 2026
- Increased$373.3M(0.46%)May 14, 2026
- Unchanged$493.1M(0.00%)Aug 13, 2026
- Increased$60.5M(34.57%)Feb 14, 2024
- Reduced$32.8M(-50.61%)May 14, 2024
- Reduced$22.5M(-34.34%)Aug 14, 2024
- Increased$32.3M(49.21%)Nov 13, 2024
- Increased$56.8M(148.03%)Feb 13, 2025
- Reduced$36.3M(-45.85%)May 14, 2025
- Reduced$22.9M(-29.40%)Aug 13, 2025
- Reduced$17.8K(-6.18%)Nov 13, 2025
- Sold$0(-100.00%)Feb 13, 2026
- Reduced$11.8M(-91.50%)Nov 14, 2024
- Reduced$4.4M(-47.79%)Feb 14, 2025
- Increased$97M(1789.81%)Jul 21, 2025
- Reduced$1.7M(-98.03%)Aug 14, 2025
- Reduced$775.5K(-45.45%)Nov 14, 2025
- Increased$19.9M(2266.67%)Feb 17, 2026
- Increased$25M(50.42%)May 15, 2026
- Reduced$26M(-21.23%)Aug 14, 2026
- $23.3MNov 14, 2024
- Increased$26.5M(60.68%)Feb 14, 2025
- Reduced$5.2M(-83.32%)May 15, 2025
- Increased$11.5M(146.67%)Aug 14, 2025
- Increased$88.5M(824.96%)Dec 9, 2025
- Increased$14.4M(26.41%)May 15, 2026
- Reduced$5.6M(-70.59%)Aug 14, 2026
- New$41.5MNov 13, 2023
- New$144.1MSep 16, 2024
Frequently asked questions
- How many institutional investors hold ELV?
- 5 tracked institutional investors disclosed a position in ELV (ELEVANCE HEALTH INC FORMERLY) in their most recent 13F filing.
- Who is the largest institutional holder of ELV?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ELV, valued at $555M.
- Did institutional ownership of ELV increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 13 increased, 13 reduced, and 1 fully exited ELV.
- What sector is ELV in?
- ELEVANCE HEALTH INC FORMERLY is classified in the Health Care GICS sector, Healthcare Plans industry.
- Where does this ELV ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.